trial · primary record
ADVM-022
Neovascular Age-related Macular Degeneration
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 69 |
| Primary completion | 2028-08 |
| Primary endpoint | Incidence of ocular and non-ocular adverse events |
| Registry ID | NCT05536973 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:31.907Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05536973
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.